grepcent public filings, reorganized for comparison

OSI SYSTEMS INC (OSIS)

CIK: 0001039065. SIC: 3674 Semiconductors & Related Devices. Latest 10-K as of: 2025-08-25.

SIC breadcrumb: Manufacturing > Electronic And Other Electrical Equipment And Components, Except Computer Equipment > SIC 3674 Semiconductors & Related Devices

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1039065. Latest filing source: 0001410578-25-001887.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-06-30 · filed 2025-08-25 · accession 0001410578-25-001887 · source: SEC companyfacts

Revenue
1,713,166,000 USD verified
Net income
149,637,000 USD verified
Assets
2,241,257,000 USD verified
Free cash flow
73,760,000 USD computed
Net margin
8.73% computed
Operating margin
12.70% computed
Revenue YoY
+11.33% computed
ROE
15.73% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

OSIS ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 3674; per-ratio N printed.OSIS ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 3674; per-ratio N printed.RatioOSISPeer medianPercentileNNet margin8.7%4.9%6059Operating margin12.7%3.7%6858Revenue growth11.3%15.5%4261FCF margin4.3%8.9%3160ROE15.7%3.8%7058ROA6.7%1.6%7261Liabilities / equity1.360.518659Current ratio2.042.701861

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 3674 Semiconductors & Related Devices, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue1,713,166,000USD20252025-08-25
Net income149,637,000USD20252025-08-25
Assets2,241,257,000USD20252025-08-25

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2025-08-25. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001039065.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2016201720182019202020212022202320242025
Revenue960,951,0001,089,286,0001,182,115,0001,166,044,0001,146,902,0001,183,236,0001,278,427,0001,538,758,0001,713,166,000
Net income91,778,000128,154,000149,637,000
Operating income38,374,00033,292,00055,908,000107,774,000104,887,000115,371,000121,749,000135,279,000189,061,000217,524,000
Gross profit276,859,000323,501,000391,652,000430,594,000420,639,000419,918,000424,427,000430,510,000530,458,000587,182,000
Diluted EPS1.301.07-1.573.464.054.036.455.347.388.71
Operating cash flow59,218,00062,779,000133,109,000119,112,000129,180,000139,066,00063,808,00094,812,000-87,501,00097,592,000
Capital expenditures17,688,00017,096,00043,198,00027,412,00021,057,00016,896,00014,921,00015,811,00022,102,00023,832,000
Share buybacks73,368,00048,453,00062,932,00021,029,00051,775,00037,468,000111,627,00034,749,0000.0080,443,000
Assets991,723,0001,230,087,0001,255,691,0001,264,864,0001,268,541,0001,384,367,0001,443,150,0001,555,686,0001,936,008,0002,241,257,000
Liabilities450,877,000660,874,000766,255,000713,137,000696,389,000744,547,000804,726,000829,521,0001,072,525,0001,290,173,000
Stockholders' equity540,846,000569,213,000489,436,000551,727,000572,152,000639,820,000638,424,000726,165,000863,483,000951,084,000
Cash and cash equivalents104,370,000169,650,00084,814,00096,316,00076,102,00080,613,00064,202,00076,750,00095,353,000106,405,000
Free cash flow41,530,00045,683,00089,911,00091,700,000108,123,000122,170,00048,887,00079,001,000-109,603,00073,760,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2016201720182019202020212022202320242025
Net margin7.18%8.33%8.73%
Operating margin3.46%5.13%9.12%9.00%10.06%10.29%10.58%12.29%12.70%
Return on equity12.64%14.84%15.73%
Return on assets5.90%6.62%6.68%
Liabilities / equity0.831.161.571.291.221.161.261.141.241.36
Current ratio1.511.891.471.681.872.061.221.471.492.04

Industry Peer Context

Each number-line places OSIS against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

OSIS Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 59.OSIS Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 59.59 SIC peersMin -101.6%Median 4.9%Max 57.7%OSIS 8.7%

Operating margin peer context

OSIS Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.OSIS Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.58 SIC peersMin -148.7%Median 3.7%Max 60.5%OSIS 12.7%

ROE peer context

OSIS ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.OSIS ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 58.58 SIC peersMin -146.9%Median 3.8%Max 76.3%OSIS 15.7%

ROA peer context

OSIS ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 61.OSIS ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 3674; peer count 61.61 SIC peersMin -95.6%Median 1.6%Max 58.1%OSIS 6.7%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Income statement bridge from reported figures

OSIS FY2025 income statement bridge from reported figures.OSIS FY2025 income statement bridge from reported figures.OSIS income bridgeFY2025: revenue to net incomeSource: SEC companyfacts FY2025.Income statement bridgeReported amount$0.0B$1.0B$2.0B$1.7BRevenue-$1.1BCost$587.2MGross-$369.7MOpEx$217.5MOperating-$67.9MOther/tax$149.6MNet income

Figure provenance: SEC companyfacts FY 2025. Revenue: accession 0001410578-25-001887; concept RevenueFromContractWithCustomerIncludingAssessedTax; source concepts us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax | Gross profit: accession 0001410578-25-001887; concept GrossProfit; source concepts us-gaap:GrossProfit | Operating income: accession 0001410578-25-001887; concept OperatingIncomeLoss; source concepts us-gaap:OperatingIncomeLoss | Net income: accession 0001410578-25-001887; concept NetIncomeLoss; source concepts us-gaap:NetIncomeLoss

Free cash flow = operating cash flow - capital expenditures

OSIS FY2025 free cash flow bridge from reported figures.OSIS FY2025 free cash flow bridge from reported figures.OSIS free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$97.6MOperating cash flow-$23.8MCapex$73.8MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001410578-25-001887; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001410578-25-001887; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001410578-25-001887; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

OSIS revenue, last 5 periods. Source: SEC companyfacts FY2025.OSIS revenue, last 5 periods. Source: SEC companyfacts FY2025.OSIS RevenueLatest point: FY2025 = $1.7BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: RevenueFromContractWithCustomerIncludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

OSIS net income, last 3 periods. Source: SEC companyfacts FY2025.OSIS net income, last 3 periods. Source: SEC companyfacts FY2025.OSIS Net incomeLatest point: FY2025 = $149.6MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0M$91.8MFY2023$128.2MFY2024$149.6MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

OSIS operating income, last 5 periods. Source: SEC companyfacts FY2025.OSIS operating income, last 5 periods. Source: SEC companyfacts FY2025.OSIS Operating incomeLatest point: FY2025 = $217.5MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

OSIS gross profit, last 5 periods. Source: SEC companyfacts FY2025.OSIS gross profit, last 5 periods. Source: SEC companyfacts FY2025.OSIS Gross profitLatest point: FY2025 = $587.2MSource: SEC companyfacts FY2025.Fiscal yearGross profit$0.0B$375.0M$750.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.

OSIS diluted eps, last 5 periods. Source: SEC companyfacts FY2025.OSIS diluted eps, last 5 periods. Source: SEC companyfacts FY2025.OSIS Diluted EPSLatest point: FY2025 = $8.71/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$5.00/share$10.00/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

OSIS operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.OSIS operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.OSIS Operating cash flowLatest point: FY2025 = $97.6MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow-$250.0M$0.0B$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

OSIS capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.OSIS capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.OSIS Capital expendituresLatest point: FY2025 = $23.8MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

OSIS share buybacks, last 5 periods. Source: SEC companyfacts FY2025.OSIS share buybacks, last 5 periods. Source: SEC companyfacts FY2025.OSIS Share buybacksLatest point: FY2025 = $80.4MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

OSIS assets, last 5 periods. Source: SEC companyfacts FY2025.OSIS assets, last 5 periods. Source: SEC companyfacts FY2025.OSIS AssetsLatest point: FY2025 = $2.2BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$2.0B$4.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: Assets. Source concepts: us-gaap:Assets.

OSIS liabilities, last 5 periods. Source: SEC companyfacts FY2025.OSIS liabilities, last 5 periods. Source: SEC companyfacts FY2025.OSIS LiabilitiesLatest point: FY2025 = $1.3BSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

OSIS stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.OSIS stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.OSIS Stockholders' equityLatest point: FY2025 = $951.1MSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$500.0M$1.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

OSIS cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.OSIS cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.OSIS Cash and cash equivalentsLatest point: FY2025 = $106.4MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

OSIS free cash flow, last 5 periods. Source: SEC companyfacts FY2025.OSIS free cash flow, last 5 periods. Source: SEC companyfacts FY2025.OSIS Free cash flowLatest point: FY2025 = $73.8MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow-$250.0M$0.0B$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-06-30; accession 0001410578-25-001887; filed 2025-08-25. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

1 tracked difference above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

View the filing-by-filing ledger →

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-05-04. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001039065.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q32022-03-312.41reported discrete quarter
2023-Q22022-12-310.96reported discrete quarter
2023-Q32023-03-31302,889,0001.27reported discrete quarter
2023-Q42023-06-30411,870,000derived Q4 = FY annual - nine-month YTD
2023-Q12023-09-300.75reported discrete quarter
2024-Q22023-12-31373,235,0002.11reported discrete quarter
2024-Q32024-03-31405,406,0001.95reported discrete quarter
2024-Q42024-06-30480,907,000derived Q4 = FY annual - nine-month YTD
2025-Q12024-09-30344,007,0001.05reported discrete quarter
2025-Q22024-12-31419,820,0002.22reported discrete quarter
2025-Q32025-03-31444,354,0002.40reported discrete quarter
2025-Q42025-06-30504,985,000derived Q4 = FY annual - nine-month YTD
2026-Q12025-09-30384,623,00020,556,0001.18reported discrete quarter
2026-Q22025-12-31464,057,00038,699,0002.22reported discrete quarter
2026-Q32026-03-31453,246,00040,216,0002.33reported discrete quarter

Quarterly Charts

OSIS quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q3.OSIS quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q3.OSIS Quarterly RevenueLatest point: 2026-Q3 = $453.2MSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Revenue$0.0B$375.0M$750.0M2023-Q32023-Q42024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q22026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001104659-26-055014; filed 2026-05-04. Concept: RevenueFromContractWithCustomerIncludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

OSIS quarterly net income, last 3 periods. Source: SEC companyfacts 2026-Q3.OSIS quarterly net income, last 3 periods. Source: SEC companyfacts 2026-Q3.OSIS Quarterly Net incomeLatest point: 2026-Q3 = $40.2MSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Net income$0.0B$125.0M$250.0M$20.6M2026-Q1$38.7M2026-Q2$40.2M2026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001104659-26-055014; filed 2026-05-04. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

OSIS quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q3.OSIS quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q3.OSIS Quarterly Diluted EPSLatest point: 2026-Q3 = $2.33/shareSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Diluted EPS (USD/share)$0.00/share$2.00/share$4.00/share2022-Q32023-Q22023-Q32023-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q22026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001104659-26-055014; filed 2026-05-04. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read OSIS's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read OSIS's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001104659-26-055014.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-05-04. Report date: 2026-03-31.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In this report, “OSI”, the “Company”, “we”, “us”, “our” and similar terms refer to OSI Systems, Inc. together with our wholly-owned subsidiaries.

This management’s discussion and analysis of financial condition as of March 31, 2026 and results of operations for the three and nine months ended March 31, 2026 should be read in conjunction with management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 filed with the SEC.

Forward-Looking Statements

This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements relate to our current expectations, beliefs, and projections concerning matters that are not historical facts. Words such as “project,” “believe,” “anticipate,” “plan,” “expect,” “intend,” “may,” “should,” “will,” “would,” and similar words and expressions are intended to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions and contingencies, many of which are outside our control. Assumptions upon which our forward-looking statements are based could prove to be inaccurate, and actual results may differ materially from those expressed in or implied by such forward-looking statements. Important factors that could cause our actual results to differ materially from our expectations are disclosed in this report, our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 (including Part I, Item 1, “Business,” Part I, Item 1A, “Risk Factors” and Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”) and other documents filed by us from time to time with the SEC. Such factors, of course, do not include all factors that might affect our business and financial condition. We could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; government shutdown; delays in revenue recognition related to the timing of customer acceptance; the impact of potential information technology, cybersecurity or data security breaches; changes in domestic and foreign government spending, budgetary, procurement, and trade policies adverse to our businesses; the impact of the Russia-Ukraine conflict or conflicts in the Middle East, including the potential for broad economic disruption and increased global tensions; global economic uncertainty, including the impact of tariffs; material delays and cancellations of orders or deliveries thereon, supply chain disruptions, plant closures, or other adverse impacts on our ability to execute business plans; unfavorable currency exchange rate fluctuations; unfavorable interest rate fluctuations; effect of changes in tax legislation, guidance and interpretations; market acceptance of our new and existing technologies, products and services; our ability to win new business and convert any orders received to sales within the fiscal year; contract and regulatory compliance matters, and actions, which if brought, could result in judgments, settlements, fines, injunctions, debarment or penalties; and other risks and uncertainties, including but not limited to those factors described in our other SEC filings. All forward-looking statements contained in this report are qualified in their entirety by this section. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Investors should not place undue reliance on forward-looking statements as a prediction of actual results. We undertake no obligation other than as may be required under securities laws to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Executive Summary

We are a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. We sell our products and provide related services in diversified markets, including homeland security, healthcare, defense and aerospace. We have three operating divisions: (a) Security, providing security and inspection systems, turnkey security screening solutions and radio frequency equipment; (b) Optoelectronics and Manufacturing, providing specialized electronic components for our Security and Healthcare divisions, as well as to third parties for applications in the defense and aerospace markets, among others; and (c) Healthcare, providing patient monitoring, cardiology and remote monitoring, and connected care systems and associated accessories.

28

Table of Contents

Security Division. Through our Security division, we provide security screening products and services globally, as well as turnkey security screening solutions. These products and services are used to inspect baggage, parcels, cargo, people, vehicles and other objects for weapons, explosives, drugs, radioactive and nuclear materials and other contraband. We also advance the application of radio frequency broadcast transmission and scientific and industrial equipment for a global customer base across various sectors.

Optoelectronics and Manufacturing Division. Through our Optoelectronics and Manufacturing division, we design, manufacture and market optoelectronic devices and flex circuits and provide electronics manufacturing services globally for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostics, telecommunications, office automation, computer peripherals, industrial automation and consumer products. We also provide our optoelectronic devices and electronics manufacturing services to OEM customers and to our own Security and Healthcare divisions.

Healthcare Division. Through our Healthcare division, we design, manufacture, market and service patient monitoring, cardiology and remote monitoring, and connected care systems globally for sale primarily to hospitals and medical centers. Our products monitor patients in critical, emergency and perioperative care areas of the hospital and provide information, through wired and wireless networks, to physicians and nurses who may be at the patient’s bedside, in another area of the hospital or even outside the hospital.

Trends and Uncertainties

The following is a discussion of certain trends and uncertainties that we believe have influenced, and may continue to influence, our results of operations.

Global Economic Considerations. Our products and services are sold in numerous countries worldwide, with a large percentage of our sales generated outside the United States. Therefore, we are exposed to and impacted by global macroeconomic factors, U.S. and foreign government policies and foreign exchange fluctuations. There is uncertainty surrounding macroeconomic factors in the U.S. and globally characterized by the supply chain environment, inflationary pressure, interest rates, and labor shortages. Increasing diplomatic and trade friction between the U.S. and China has also created significant uncertainty in the global economy. These global macroeconomic factors, coupled with political unrest internationally and the volatile U.S. political climate, have created uncertainty and impacted demand for certain of our products and services. The continued conflict between Russia and Ukraine and in the Middle East and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. While the impact of these factors remains uncertain, we will continue to evaluate the extent to which these factors will impact our business, financial condition or results of operations. We do not know how long this uncertainty will continue. These factors could have a material adverse effect on our business, results of operations and financial condition.

Global Trade. The current domestic and international political environment, including in relation to recent and further potential changes by the U.S. and other countries in policies on global trade and tariffs, have resulted in uncertainty surrounding the future state of the global economy and global trade. This uncertainty is exacerbated by sanctions imposed by the U.S. government against certain businesses and individuals in select other countries. Tariffs and trade restrictions and retaliatory measures by such other countries could result in revenue reductions for the Company or cost increases on material used in our products. We are taking measures to contain costs to reduce the impact of tariffs and to date, such measures have helped reduce our exposure to these conditions. Continued or increased uncertainty regarding global trade due to these or other factors may require us to modify our current business practices and could have a material adverse effect on our business, financial condition, results of operations and cash flows.

Supply and Demand for Memory and Semiconductor Components. We have experienced tighter supply conditions and increased costs for certain memory associated and semiconductor components, reflecting a broader global imbalance between supply and demand for memory used in data center and AI related infrastructure. While we have taken actions to mitigate these impacts, continued constraints in component availability could adversely affect our business.

Healthcare Considerations. Certain hospitals are facing significant financial pressure as supply chain constraints and inflation drive up operating costs. To the extent macroeconomic conditions remain challenging, it is likely that hospitals’ spend on capital equipment will be adversely impacted.

Government Policies. Our results of operations and cash flows could be materially affected by changes in U.S. or foreign government legislative, regulatory or enforcement policies, as well as potential or actual U.S. government shutdowns, including the impact on near-term bookings and revenues of the recent Department of Homeland Security shutdown.

29

Table of Contents

Russia’s Invasion of Ukraine. The invasion of Ukraine by Russia and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. This has the potential to indirectly disrupt our supply chain and access to certain resources. While we have not experienced material adverse impacts to date resulting from this conflict, we have certain research and development activities within Ukraine for our Healthcare division which have been somewhat impacted. The conflicts also have increased the threat of malicious cyber-activity from other countries and other actors.

Military Conflicts and Geopolitical Tensions in the Middle East. Ongoing military conflicts and geopolitical tensions in the Middle East, including involving Iran, may adversely affect global markets, energy prices, supply chain reliability, transportation networks, customer demand, and investor confidence, which could materially impact demand for our products and services from our customers, timing of delivery of products and services, and our results of operations.

In light of the ongoing conflicts and heightened global instabili

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001410578-25-001887. The complete FY 2025 MD&A is published at /company/OSIS/mda/fy2025/.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2025-08-25. Report date: 2025-06-30.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following management’s discussion and analysis of financial condition and results of operations (“MD&A”) is intended to help the reader understand our results of operations and financial condition. MD&A is provided as a supplement to, and should be read in conjunction with, our financial statements and the accompanying notes. This MD&A contains forward-looking statements and the matters discussed in these forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those projected or implied in the forward-looking statements. Please see “Risk Factors” and “Forward-Looking Statements” for a discussion of the uncertainties, risks and assumptions associated with these statements.

36

Table of Contents

Overview

We are a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. We sell our products and provide related services in diversified markets, including homeland security, healthcare, defense and aerospace. We have three operating divisions, each of which is a reportable segment: (a) Security, providing security and inspection systems and turnkey security screening solutions; (b) Optoelectronics and Manufacturing, providing specialized electronic components and electronic manufacturing services for our Security and Healthcare divisions, as well as to third parties for applications in the defense and aerospace markets, among others; and (c) Healthcare, providing patient monitoring, cardiology and remote monitoring, and connected care systems and associated accessories.

Security Division. Through our Security division, we provide security screening products, multi-platform software solutions, and services globally, as well as turnkey security screening solutions. These products and services are used to inspect baggage, parcels, cargo, people, vehicles and other objects for weapons, explosives, drugs, radioactive and nuclear materials and other contraband. Revenues from our Security division accounted for 70% of our total consolidated revenues for fiscal 2025.

Optoelectronics and Manufacturing Division. Through our Optoelectronics and Manufacturing division, we design, manufacture and market optoelectronic devices and flex circuits and provide electronics manufacturing services globally for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostics, telecommunications, office automation, computer peripherals, industrial automation, and consumer products. We also provide our optoelectronic devices and electronics manufacturing services to OEM customers, and our own Security and Healthcare divisions. Revenues from external customers in our Optoelectronics and Manufacturing division accounted for 20% of our total consolidated revenues for fiscal 2025.

Healthcare Division. Through our Healthcare division, we design, manufacture, market and service patient monitoring, cardiology and remote monitoring, and connected care systems globally for sale primarily to hospitals and medical centers. Our products monitor patients in critical, emergency and perioperative care areas of the hospital and provide information, through wired and wireless networks, to physicians and nurses who may be at the patient’s bedside, in another area of the hospital or even outside the hospital. Revenues from our Healthcare division accounted for 10% of our total consolidated revenues for fiscal 2025.

Consolidated Results

Discussion and analysis of our financial condition and results of operations for fiscal 2023 (compared with fiscal 2024) have been omitted from this Annual Report on Form 10-K, and is available in Item 7 of Part II, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended June 30, 2024.

Fiscal 2025 Compared with Fiscal 2024. We reported consolidated net revenue of $1,713.2 million in fiscal 2025, a 11.3% increase compared to the prior year. Our income from operations increased to $ 217.5 million in fiscal 2025 or 15% growth from the prior year driven primarily by increased net revenue of $174.4 million which increased associated gross profit by $56.7 million, partially offset by and an increase in operating expenses of $28.3 million.

Acquisitions. We acquired two businesses in fiscal 2025 and two businesses in fiscal 2024, as described in Note 2 to the Consolidated Financial Statements. None of these acquisitions was considered material.

37

Table of Contents

Trends and Uncertainties

The following is a discussion of certain trends and uncertainties that we believe have influenced, and may continue to influence, our results of operations.

Global Economic Considerations. Our products and services are sold in numerous countries worldwide, with a large percentage of our sales generated outside the United States. Therefore, we are exposed to and impacted by global macroeconomic factors, U.S. and foreign government policies and foreign exchange fluctuations. There is uncertainty surrounding macroeconomic factors in the U.S. and globally characterized by the supply chain environment, inflationary pressure, rising interest rates, and labor shortages. Increasing diplomatic and trade friction between the U.S. and China has also created significant uncertainty in the global economy. These global macroeconomic factors, coupled with the volatile U.S. political climate and political unrest internationally, have created uncertainty and impacted demand for certain of our products and services. Conflicts in Gaza and nearby regions have created political and economic uncertainty in the Middle East. Also, the continued conflict between Russia and Ukraine and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. While the impact of these factors remains uncertain, we will continue to evaluate the extent to which these factors will impact our business, financial condition or results of operations. We do not know how long this uncertainty will continue. These factors could have a material adverse effect on our business, results of operations and financial condition.

Global Trade. The current domestic and international political environment, including in relation to recent and further potential changes by the U.S. and other countries in policies on global trade and tariffs, have resulted in uncertainty surrounding the future state of the global economy and global trade. This uncertainty is exacerbated by sanctions imposed by the U.S. government against certain businesses and individuals in select countries. Tariffs, trade restrictions and retaliatory measures could result in revenue reductions or cost increases on material used in our products, which could materially and adversely affect our business, financial condition, results of operations and cash flows. Consistent with our strategy, we are taking measures to contain costs to reduce the impact of tariffs. To date, our strategies have helped minimize our exposure to these conditions. Continued or increased uncertainty regarding global trade due to these or other factors may require us to modify our current business practices and could have a material adverse effect on our business, results of operations and financial condition.

Healthcare Considerations. Certain hospitals are facing significant financial pressure as supply chain constraints and inflation drive up operating costs and higher interest rates make access to credit more expensive. To the extent macroeconomic conditions remain challenging, it is likely that hospitals’ spend on capital equipment will be adversely impacted.

Russia-Ukraine and Israel-Hamas Conflicts. The invasion of Ukraine by Russia and the sanctions imposed in response to this conflict as well as the Israel-Hamas conflict have increased global economic and political uncertainty. This has the potential to indirectly disrupt our supply chain and access to certain resources. While we have not experienced significant adverse impacts to date resulting from these conflicts, we have certain research and development activities within Ukraine for our Healthcare division which have been somewhat impacted. The conflicts also have increased the threat of malicious cyber-activity from other countries and other actors.

Currency Exchange Rates. On a year-over-year basis, currency exchange rates positively impacted reported sales by approximately 0.4% for the year ended June 30, 2025 compared to the year ended June 30, 2024, primarily due to the weakening of the U.S. dollar against other foreign currencies in fiscal 2025. Any strengthening of the U.S. dollar against foreign currencies would adversely impact our sales in future periods, and any weakening of the U.S. dollar against foreign currencies would positively impact our sales in future periods.

Significant International Security Contracts. During fiscal years 2023 and 2024, our Security division was awarded three significant international contracts valued in aggregate greater than $800 million During fiscal years 2023, 2024 and 2025, we recognized revenues generated from these contracts of approximately $17 million, $404 million and $231 million, respectively. Further revenues are expected to be recognized in fiscal year 2026 and beyond, albeit at relatively lower amounts as we have fulfilled the majority of equipment deliveries as of the end of fiscal year 2025.

38

Table of Contents

Critical Accounting Policies and Estimates

The following discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Our preparation of these consolidated financial statements requires us to make judgments and estimates that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. As a result, actual results may differ from such estimates. Our senior management has reviewed these critical accounting policies and estimates and related disclosures with the Audit Committee of our Board of Directors. The following summarizes our critical accounting policies and estimates used in preparing our consolidated financial statements:

Revenue Recognition. We recognize revenue when performance obligations under the terms of the contracts with our customers are satisfied. Our performance obligations are broadly categorized as product sales, service revenue, and project-specific contract revenue. Revenue from sales of products is recognized upon shipment or delivery when control of the product transfers to the customer, depending on the terms of each sale, and when collection is probable. Revenue from services includes installation and implementation of products and turnkey security screening services and after-market services. Generally, revenue from services is recognized over time as the services are performed. Sales agreements with customers can be project specific, cover a period of time, and can be renewable periodically. The contracts may contain terms and conditions with respect to payment, delivery, installation, services, warranty and other rights. Contracts with customers may include the sale of products and services.

In certain instances, contracts with customers can contain multiple performance obligations such as civil works to prepare a site f

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for OSIS

Indicators mapped to this company's SIC classification (industry 3674 Semiconductors & Related Devices) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Inflation (CPI / PCE / PPI), US labor market, Growth & output, Money & trade, Government finances, Sector employment, Industrial orders & inventories, Trade & external.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/OSIS.md · JSON record: /company/OSIS.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt